PUBLISHED FOR OPPOSITION
on 10 Dec 2024
Last Applicant/ Owned by
2/B Mahalaxmi Chamber
Mumbai
IN
400026
Serial Number
98384819 filed on 31st Jan 2024
Registration Number
N/A
Correspondent Address
Maxim A. Voltchenko
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
IGI
Scientific research for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Providing information in the field of medicine and health; medical services; medical assistance services; hygiene care for human beings being health care services; medical clinic services; providing medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific research for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; pharmaceutical research and development; research and development for new products for others; scientific and technological services, namely, scientific research and analysis in the field of chemicals, pharmaceutical preparations, dietetic preparations, demo-cosmetic preparations, and biotechnology; design and testing for new product development; medical research; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services; scientific research services for medical purposes, namely, bacteriological research services; biomedical research services; laboratory research services in the field of cancer treatment, oncology, immunology and pain management; medical and scientific research, namely, conducting clinical trials for others; scientific research in the field of pharmacology; medical research services conducted in a laboratory; scientific and technological services, namely, scientific research and analysis, in the fields of medicine, health, fitness, exercise and wellness; consulting services in the field of pharmaceutical research and development, namely, consultation and collaboration with industry and academic professionals for the identification, research and development of new manufacturing technologies in the field of pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Spirometer; inhalers for therapeutic use, sold empty; chambers for inhalers; nebulizers for medical purposes; diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for testing DNA and RNA samples
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain; preparations for the treatment of asthma
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [003]
Cosmetics and Cleaning Products
Skin soaps; shampoos; sunscreen for cosmetic use; perfumery; essential oils; body powder; cosmetics; anti-aging creams; hair lotion; skin creams; skin moisturizing gels; non-medicated soaps for face; moisturizing body lotions; non-medicated mouthwashes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98384819
Mark Type
No Service Mark
Attorney Docket Number
No 4007-118tmus
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
24.15.10 -
More than one arrow
26.01.21 -
Circles that are totally or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Dec 2024 | PUBLISHED FOR OPPOSITION |
| 04th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 18th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 15th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 14th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 14th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Aug 2024 | NON-FINAL ACTION E-MAILED |
| 26th Aug 2024 | ASSIGNED TO EXAMINER |
| 26th Aug 2024 | NON-FINAL ACTION WRITTEN |